Relation between psychosocial variables and the glycemic control of patients with type 2 diabetes: A cross-sectional and prospective study

Table 1 Baseline demographic, clinical and psychosocial characteristics of patients with type 2 diabetes

	Total	followed for one year (a)	not followed (n = 14)
Baseline variables	(n = 304)	(n = 290)	dropouts (n = 10)	died (n = 4)
Demographic variables
Sex(M/F)	170/134	161/129	6/4	3/1
Age (y)	61.9 ± 11	61.1 ± 11	57.4 ± 12	70.5 ± 8.2
Duration of illness (y)	11.6 ± 8.1	11.6 ± 10	8.8 ± 7.2	14.0 ± 3.6
Clinical variables
HbA_1c (%)	7.30 ± 1.2	7.32 ± 1.2	6.72 ± 0.88	7.83 ± 1.3
Treatment regimen (diet only/medication)	63/241	59/231	4/6	0/4
No. of microvascular complications of diabetes (0/1/2/3)	116/79/60/49	107/77/60/46	9/0/0/1	0/2/0/2
Psychosocial variables (score)
DTSQ	25.3 ± 6.4	25.2 ± 6.4	28.0 ± 5.5	26.3 ± 7.4
W-BQ12	23.8 ± 6.7	23.8 ± 6.6	25.5 ± 8.1	20.0 ± 9.1
PAID	33.0 ± 21	33.4 ± 21	21.5 ± 23	37.2 ± 25
SES	35.2 ± 6.2	35.3 ± 6.2	32.6 ± 6.9	38.3 ± 5.4
Social Support Scale	56.2 ± 17	56.4 ± 16	48.1 ± 18	61.3 ± 22
Self-Efficacy Scale	74.0 ± 12	73.9 ± 12	75.9 ± 13	76.0 ± 8.8

Values are mean ± SD or n. Medication, oral hypoglycemic agents, or insulin, or insulin plus oral hypoglycemic agents. DTSQ, Diabetes Treatment Satisfaction Questionnaire measures satisfaction with the current therapy for diabetes; W-BQ12, Well-being Questionnaire12 measures the psychological well-being of patients with diabetes; PAID, Problem Areas in Diabetes Scale measures diabetes-specific emotional distress; SES, Self-Esteem Scale measures global self-esteem; Social Support Scale measures the degree of social support in daily life for chronic disease; Self-Efficacy Scale measures self-efficacy in dealing with health behavior in chronic disease.

ISSN: 1751-0759